heparan
sulfat
proteoglycan
hspg
compos
core
protein
coval
link
glycosaminoglycan
gag
chain
form
unbranch
sulfat
anion
polysaccharid
known
heparan
sulfat
hs
figur
addit
hs
gag
includ
chondroitin
sulfat
dermatan
sulfat
keratan
sulfat
hyaluron
acid
major
hspg
anchor
plasma
membran
almost
eukaryot
cell
except
perlecan
agrin
collagen
xvii
present
extracellular
matrix
ecm
syndecan
glypican
figur
two
main
class
membraneanchor
hspg
syndecan
encod
differ
gene
repres
abund
transmembran
hspg
core
protein
compos
extracellular
domain
singl
transmembran
domain
short
cytoplasm
domain
interact
cell
cytoskeleton
glypican
encod
differ
gene
anchor
cell
membran
via
glycosylphosphatidylinositol
gpi
synthesi
hspg
initi
attach
first
tetrasaccharid
ie
xylos
galactos
galactos
glucuron
acid
serin
residu
ser
core
protein
figur
subsequ
addit
nacetyl
glucosamin
glcnac
glucuron
acid
glca
five
differ
glycotransferas
term
exostosin
mediat
attach
nacetyl
group
glcnac
replac
sulfat
group
ndeacetylasensulfotransferas
subsequ
step
involv
epimer
glca
iduron
acid
idua
glucuronyl
gcla
epi
final
osulfotransferas
ost
ie
modifi
hspg
result
organ
human
bodi
contain
differ
isoform
hspg
variou
saccharid
composit
sulfat
pattern
sever
enzym
involv
degrad
hspg
particular
involv
physiolog
patholog
role
similar
enzym
express
also
bacteria
use
tool
modifi
hspg
cell
surfac
investig
involv
viral
infect
hspg
conserv
among
vertebr
invertebr
multipl
function
figur
compon
ecm
contribut
basal
membran
organ
mediat
cell
adhes
motil
part
secretori
vesicl
serglycin
particular
ensur
correct
function
pack
content
ie
proteas
matrix
protein
cell
surfac
hspg
bind
cytokin
chemokin
growth
factor
morphogen
prevent
degrad
thu
creat
temporari
storag
site
gradient
morphogen
import
develop
express
cell
surfac
also
serv
endocytosi
receptor
therebi
regul
lysosom
degrad
extracellular
molecul
provid
nutrient
cell
moreov
involv
endocytosi
cellular
receptor
mediat
transcellular
transport
chemokin
across
endotheli
cell
also
serv
coreceptor
fibroblast
growth
factor
fgf
fgf
receptor
ci
express
cell
tran
express
differ
cell
mediat
intracellular
signal
intracellular
stress
proteolyt
shed
syndecan
import
role
develop
maintain
stem
cell
nich
detail
descript
hspg
physiolog
patholog
morpholog
function
beyond
aim
review
found
mammal
hspg
ubiquit
express
cell
type
due
heavili
sulfat
gag
chain
present
global
neg
charg
interact
electrostat
basic
residu
viral
surfac
glycoprotein
viral
capsid
protein
nonenvelop
virus
virus
exploit
weak
interact
increas
concentr
cell
surfac
augment
chanc
bind
specif
entri
receptor
rare
case
hspg
serv
directli
entri
receptor
describ
herp
simplex
viru
hsv
hspgdepend
virus
group
distinct
categori
tabl
list
exampl
categori
hsv
belong
herpesvirida
famili
includ
larg
envelop
doublestrand
dna
dsdna
virus
whose
manifest
rang
asymptomat
infect
mild
mucocutan
lesion
lip
cornea
genit
skin
sever
even
lifethreaten
infect
enceph
dissemin
infect
neonat
immunocompromis
host
caus
mainli
herp
labiali
transmit
intim
oral
contact
caus
herp
genitali
transmit
sexual
intercours
follow
primari
infect
genit
oral
mucosa
hsv
establish
latent
infect
neuron
sensori
ganglia
may
reactiv
caus
recurr
lesion
site
primari
infect
current
vaccin
avail
activ
antivir
acyclovir
interfer
viral
dna
synthesi
exist
use
hspg
attach
cell
surfac
absenc
hspg
express
total
abolish
infect
rate
decreas
significantli
viru
rare
bind
directli
entri
receptor
two
viral
surfac
glycoprotein
gb
gc
first
interact
hspg
particular
interact
hspgrich
filopodialik
structur
primari
conjunctiv
epitheli
cell
neuron
interact
enabl
viru
move
along
protrus
process
refer
viral
surf
reach
cellular
bodi
entri
receptor
express
specif
interact
gd
differ
receptor
member
immunoglobulin
famili
hvea
herpesviru
entri
mediat
member
tumor
necrosi
factor
tnf
protein
mediat
entri
receptor
use
differ
depend
cell
type
interestingli
hs
type
hspg
suffici
mediat
attach
fusion
primari
corneal
fibroblast
hvea
express
moreov
solubl
form
mediat
infect
cell
line
viru
attach
enter
bind
entri
receptor
gd
undergo
conform
chang
allow
viral
fusion
surfac
glycoprotein
gh
gl
also
play
fundament
role
process
form
fusion
complex
togeth
gd
gb
necessari
releas
tegument
protein
viral
dna
host
cell
interestingli
recent
studi
highlight
hsv
induc
heparanas
overexpress
infect
cell
facilit
detach
spread
mechan
prevent
viru
trap
cell
surfac
receptor
bind
cleavag
sialic
acid
influenza
neuraminidas
sever
sulfat
molecul
ie
heparin
carrageenan
dendrim
nanoparticl
other
inhibit
hsv
infect
support
role
hs
viral
attach
tabl
human
papillomaviru
hpv
small
nonenvelop
dsdna
viru
papillomavirida
famili
infect
epitheli
cell
skin
anogenit
oropharyng
mucosa
caus
benign
malign
neoplast
lesion
hpv
common
sexual
transmit
virus
subdivid
lowrisk
type
caus
lowgrad
cervic
lesion
genit
wart
highrisk
type
caus
cervix
carcinoma
well
anu
vulva
vagina
peni
oropharynx
cancer
vaccin
avail
approv
antivir
sever
type
hpv
also
bovin
papillomavirus
depend
hspg
vitro
vivo
believ
papillomavirus
depend
hspg
initi
attach
howev
due
oncogen
potenti
preval
serotyp
whose
entri
studi
hpv
start
infecti
cycl
basal
membran
vagin
mucosa
exploit
abras
lesion
epithelium
first
contact
mediat
mainli
hspg
express
cellular
surfac
basal
keratinocyt
ecm
role
formerli
term
attach
also
propos
play
major
role
initi
attach
due
express
epitheli
cell
overproduct
wound
heal
depend
hspg
demonstr
vitro
also
vivo
mice
pretreat
topic
heparinas
iii
treat
time
infect
heparin
infect
presenc
treatment
signific
decreas
infect
observ
critic
residu
interact
hspg
hpv
map
expos
portion
capsid
protein
contact
hspg
hpv
capsid
undergo
conform
chang
assist
extracellular
cyclophilin
b
cleavag
capsid
protein
furin
lead
loss
affin
hspg
bind
differ
secondari
receptor
identif
intern
receptor
ongo
integrin
epiderm
growth
factor
receptor
egfr
tetraspanin
famili
may
involv
entri
kinet
hpv
appear
asynchron
slower
major
virus
caus
still
fulli
understood
research
suggest
may
link
cell
cycl
phase
engag
multipl
receptor
subsequ
viru
intern
endocytosi
contradictori
report
differ
hpv
type
cell
howev
entri
pseudovirion
epitheli
cell
independ
clathrin
caveola
suggest
common
endocyt
pathway
hpv
sever
hspgmimick
interact
molecul
small
molecul
dendrim
carrageenan
heparin
nanoparticl
proven
effect
prevent
hpv
infect
tabl
carrageenanbas
gel
test
carraguard
phase
iib
clinic
trial
treat
arm
show
enhanc
protect
compar
placebo
arm
howev
despit
promis
effect
microbicid
hpv
phase
iib
clinic
trial
phase
iii
clinic
trial
perform
may
link
failur
trial
similar
compound
hiv
tabl
dengu
viru
denv
envelop
positivesens
singlestrand
rna
ssrna
viru
flavivirida
famili
compos
distinct
serotyp
billion
peopl
live
area
risk
dengu
transmiss
approxim
million
denv
infect
report
yearli
lead
death
viru
mainli
transmit
aed
mosquito
bite
infect
individu
asymptomat
display
dengu
fever
selflimit
diseas
howev
especi
secondari
infect
differ
denv
serotyp
viru
caus
dengu
hemorrhag
fever
dhf
dengu
shock
syndrom
dss
lead
death
first
demonstr
denv
bind
hspg
report
highli
sulfat
liverderiv
hs
well
heparin
shown
inhibit
moreov
alter
gag
express
sulfat
cell
reduc
denv
infect
demonstr
treatment
vero
cell
heparinas
iii
sodium
chlorat
sulfat
inhibitor
infect
cho
cell
line
lack
hspg
synthesi
hspg
depend
also
demonstr
competit
experi
numer
sulfat
molecul
see
tabl
interact
site
hspg
map
subsequ
domain
iii
dengu
envelop
e
protein
extern
loop
region
rich
surfac
basic
residu
time
numer
paper
publish
interact
e
protein
hspg
human
endotheli
liver
anim
cell
line
unclear
also
interact
hspg
insect
cell
line
moreov
exclud
effect
link
cell
adapt
denv
pseudoparticl
produc
sequenc
e
prematrix
prm
protein
virus
never
passag
cell
shown
bind
hspg
heparin
manner
compar
virus
extens
passag
cell
line
human
cell
line
hspg
well
proven
first
attach
receptor
follow
specif
interact
one
known
entri
receptor
dendrit
intercellular
adhes
nonintegrin
dcsign
mannos
receptor
mr
macrophag
proteinac
receptor
varieti
receptor
demonstr
involv
denv
entri
may
relat
wide
varieti
tissu
infect
liver
lymph
node
spleen
bone
marrow
rhinovirus
rv
small
ssrna
virus
enteroviru
genu
picornavirida
famili
main
caus
acut
viral
infect
worldwid
immunocompet
individu
rv
typic
induc
common
cold
nasal
congest
rhinorrhea
cough
sneez
sore
throat
malais
spontan
resolut
within
week
howev
rv
also
caus
wide
rang
complic
ill
exacerb
asthma
chronic
obstruct
pulmonari
diseas
pneumonia
bronchiol
well
chronic
infect
immunocompromis
host
fatal
outcom
case
group
virus
consist
numer
type
organ
speci
rva
type
rvb
type
rvc
type
rva
rvb
bind
intercellular
adhes
molecul
cell
entri
belong
major
group
rv
rva
use
lowdens
lipoprotein
receptor
famili
ldlr
belong
minor
group
rv
major
group
rv
also
use
hspg
addit
receptor
either
directli
multipl
passag
cell
lack
hspgdepend
variant
increas
suscept
acid
ph
elev
temperatur
suggest
greater
instabl
might
compens
absenc
uncoat
activ
loss
virul
vivo
third
rv
speci
rvc
use
cadherinrel
famili
member
infect
cell
specif
express
ciliat
cell
airway
epithelia
explain
rvc
grow
standard
cell
howev
exogen
express
hela
cell
render
cell
permiss
rvc
serial
passag
cell
lead
increas
viral
bind
viral
yield
stronger
cytopath
effect
mutat
extern
surfac
capsid
protein
identifi
major
adapt
viral
popul
demonstr
confer
enhanc
hsmediat
cell
bind
adapt
viru
also
abl
replic
hela
cell
lack
although
lower
extent
well
primari
differenti
bronchial
cell
addit
rhinovirus
member
enteroviru
ev
b
speci
coxsacki
viru
cultureadapt
echovirus
lowpassag
clinic
echoviru
isol
echoviru
bind
hspg
natur
receptor
decayacceler
factor
daf
coxsacki
adenoviru
receptor
car
possibl
select
cell
adapt
hsbind
variant
viru
associ
mutat
chang
cellular
tropism
lytic
infect
wider
spectrum
cell
line
oppos
parent
strain
similarli
footandmouth
diseas
viru
fmdv
member
aphthoviru
genu
picornavirida
famili
also
adapt
easili
hs
bind
tissu
cultur
select
posit
amino
acid
within
capsid
protein
conclus
despit
major
picornavirida
famili
member
report
bind
receptor
especi
cell
cultur
adapt
abl
bind
hspg
note
virus
becom
hspgdepend
cell
line
similar
adapt
may
occur
human
infect
promot
replic
hspgenrich
tissu
next
paragraph
highlight
exampl
nonenvelop
ssrna
viru
picornavirida
famili
typic
transmit
via
rout
countri
high
hygien
level
transmiss
also
occur
via
respiratori
rout
one
major
caus
agent
mild
selflimit
hand
foot
mouth
diseas
hfmd
outbreak
asiapacif
region
rare
case
particularli
immunocompromis
patient
children
year
old
viru
dissemin
central
nervou
system
lead
sever
fatal
neurolog
complic
effect
antivir
treatment
current
avail
infect
howev
chines
food
drug
administr
fda
approv
two
inactiv
vaccin
genogroup
preval
genogroup
area
infect
cell
via
two
entri
receptor
trigger
viral
uncoat
rna
releas
cytoplasm
scaveng
receptor
class
b
member
major
transmembran
lysosom
protein
pselectin
glycoprotein
primarili
express
leukocyt
interact
specif
strain
addit
use
varieti
differ
attach
receptor
hspg
sialic
acid
nucleolin
vimentin
annexin
ii
receptor
enhanc
viral
infect
may
contribut
viral
dissemin
neurotrop
viral
genom
analysi
clinic
specimen
isol
directli
immunocompromis
patient
dissemin
infect
reveal
intrahost
adapt
singl
mutat
capsid
protein
ie
substitut
neutral
leucin
posit
charg
arginin
present
blood
cerebrospin
fluid
csf
gastrointestin
tract
absent
respiratori
tract
specimen
immunocompromis
patient
oppos
variant
show
hspgbind
abil
inhibit
highli
sulfat
carrageenan
vero
cell
neural
cell
cultur
underlin
fact
hs
analog
promis
compound
prevent
replic
dissemin
data
set
suggest
adapt
vivo
toward
hsdepend
variant
promot
viral
dissemin
neurotrop
immunosuppress
patient
polyomavirus
belong
famili
polyomavirida
nonenvelop
dsdna
virus
virus
persist
infect
major
popul
primari
infect
occur
earli
childhood
persontoperson
contact
contamin
surfac
howev
healthi
individu
show
sign
diseas
immunocompromis
patient
virus
reactiv
caus
patholog
current
vaccin
antivir
avail
polyomavirus
major
virus
hemagglutin
erythrocyt
due
bind
sialic
acid
expos
gangliosid
member
famili
report
bind
hspg
natur
merkel
cell
polyomaviru
viru
associ
lethal
skin
cancer
elderli
immunocompromis
viru
depend
hspg
initi
attach
phase
demonstr
lack
bind
hspgdefici
cho
cell
line
inhibit
heparinas
treatment
subsequ
step
viru
interact
sialic
acid
mediat
entri
anoth
member
polyomavirida
jcv
immunocompromis
individu
aid
patient
jcv
respons
progress
multifoc
leukoencephalopathi
pml
lead
rapid
demyelin
central
nervou
system
consequ
cognit
impair
motor
dysfunct
jcv
receptor
cell
sialic
acid
residu
lactoseri
tetrasaccharid
c
ltsc
pentasaccharid
serotonin
receptor
r
howev
viru
isol
urin
healthi
subject
differ
isol
patient
pml
form
mutat
major
capsid
protein
recent
studi
show
mutant
increas
hspg
bind
activ
demonstr
decreas
abil
bind
cell
heparinas
treatment
increas
heparin
inhibit
compar
parent
nonmut
strain
mutat
differ
bind
confer
abil
infect
neural
cell
known
express
high
level
glypican
syndecan
human
rsv
envelop
ssrna
orthopneumoviru
genu
pneumovirida
famili
primari
caus
bronchiol
pneumonia
children
year
age
also
link
respiratori
complic
immunocompromis
elderli
estim
rsv
caus
global
acut
lower
respiratori
infect
million
children
age
less
year
million
hospit
admiss
death
vaccin
current
avail
approv
specif
treatment
palivizumab
monoclon
antibodi
direct
rsv
fusion
f
protein
immunoglobulin
use
prophylaxi
limit
preterm
lowweight
immunocompromis
infant
rsv
bind
cell
involv
initi
interact
basic
amino
acid
present
viral
envelop
protein
g
f
neg
charg
hspg
subsequ
viru
engag
secondari
receptor
nucleolin
motif
chemokin
receptor
annexin
ii
interact
induc
conform
chang
f
protein
exposur
fusion
peptid
promot
fusion
viral
envelop
cell
plasma
membran
releas
nucleocapsid
cytoplasm
competit
experi
heparin
sulfat
molecul
enzymat
remov
hspg
cellular
surfac
well
inhibit
sulfat
shown
rsv
initi
attach
cell
hspgdepend
tabl
howev
recent
studi
human
airway
epitheli
hae
cultur
shown
hs
limit
express
apic
side
compar
basal
side
rsv
known
infect
mainli
apic
ciliat
cell
respiratori
epithelia
therefor
propos
rsv
bind
differ
receptor
cell
hae
suffici
mediat
infect
nonetheless
compound
relat
hspg
also
proven
inhibitori
hae
vivo
tabl
hspg
bind
site
distinct
spatial
close
therefor
hspg
mimet
may
inhibit
infect
via
steric
hindranc
knowledg
studi
hae
clinic
isol
investig
whether
hspg
bind
link
cellular
adapt
properti
rsv
strain
latter
case
receptor
may
use
viru
vivo
infect
cell
express
hspg
alveoli
yet
unidentifi
cell
inde
hae
repres
upper
respiratori
tract
airway
hspg
particular
abund
alveolar
epithelia
rsv
complic
associ
lower
respiratori
infect
altern
restrict
hspg
express
apic
side
hae
may
also
due
artifact
link
hae
differenti
vitro
immunostain
hspg
express
human
biopsi
would
aid
understand
specif
role
receptor
rsv
infect
moreov
consider
extend
member
pneumovirida
famili
particularli
human
metapneumoviru
hmpv
also
bind
hspg
infect
ciliat
cell
hae
whose
inhibit
sulfat
molecul
also
shown
hae
tabl
zikv
belong
flavivirida
famili
envelop
ssrna
viru
recent
associ
birth
defect
south
america
due
abil
viru
cross
placent
barrier
infect
neural
system
fetu
caus
microcephali
suspect
case
zikv
report
paho
pan
american
health
organ
januari
januari
america
entri
mechan
fulli
elucid
although
due
phylogenet
similar
propos
similar
denv
studi
use
surfac
plasmon
reson
spr
bind
assay
kim
colleagu
show
zikv
e
protein
interact
hs
chondroitin
sulfat
author
calcul
bind
constant
kd
nm
denv
e
protein
nm
ascrib
variat
higher
number
basic
residu
denv
e
protein
compar
zikv
howev
result
success
studi
use
full
viru
instead
purifi
e
protein
indic
depend
zikv
hspg
two
studi
neg
charg
molecul
prove
activ
zikv
inhibit
hspg
bind
tan
et
al
report
suramin
effect
zikv
howev
infect
zikv
cell
line
diminish
sodium
chlorat
wash
heparinas
iiii
treatment
possibl
observ
interact
viru
heparinsepharos
bead
molecular
dynam
simul
author
evidenc
strong
interact
suramin
zikv
helicas
possibl
explain
inhibitori
activ
second
studi
heparin
poorli
effect
zikv
mainli
inhibit
caspas
iii
apoptot
pathway
protect
cell
cell
death
rather
effect
viral
adhes
cell
addit
studi
show
hspg
present
mosquito
differ
human
anatom
site
known
effici
infect
zikv
nevertheless
viru
preincub
differ
heparin
variant
protect
viral
titer
also
increas
research
clinic
isol
serial
passag
vero
cell
identifi
mutat
domain
iii
zikv
e
protein
possibl
verifi
involv
attach
cell
hspg
enhanc
viral
infect
combin
mutat
nonstructur
protein
controversi
result
suggest
zikv
although
close
relat
denv
depend
hspg
exclus
spr
studi
zikv
e
protein
use
contradictori
result
also
emerg
studi
host
gene
necessari
viral
replic
identifi
zikv
well
denv
requir
express
two
enzym
hs
biosynthet
pathway
howev
anoth
studi
show
zikv
bind
cell
affect
inactiv
solut
carrier
famili
member
gene
involv
sulfat
hspg
result
obtain
glycosyltransferas
inactiv
gene
effect
prevent
denv
bind
howev
zikv
intracellular
rna
knockout
cell
reduc
earli
time
point
subsequ
increas
compar
wildtyp
cell
effect
relat
inhibit
cell
death
therefor
pleiotrop
effect
hspg
zikv
cell
cycl
warrant
investig
hspg
highli
express
almost
human
tissu
virus
bind
receptor
thu
expect
broader
tropism
inde
report
support
associ
hspg
bind
virul
contrari
other
show
invers
correl
usag
receptor
virul
dissemin
abil
hspg
bind
promot
hiv
neurovirul
allow
infect
endotheli
cell
express
facilit
cross
barrier
increas
neurovirul
also
describ
natur
isol
north
american
eastern
equin
enceph
viru
compar
mutant
impair
hspg
bind
abil
observ
made
strain
sindbi
viru
glutamatetohistidin
substitut
e
protein
compar
nonmut
counterpart
discuss
hspgbind
mutant
isol
blood
csf
patient
dissemin
infect
variant
increas
number
posit
charg
amino
acid
capsid
protein
also
frequent
isol
patient
neurolog
complic
altogeth
data
support
associ
dissemin
neurovirul
hs
depend
human
howev
sever
anim
experi
show
opposit
associ
fmdv
yellow
fever
viru
yfv
strain
adapt
bind
hspg
cell
less
prone
dissemin
anim
model
vein
inocul
hspgdepend
variant
hspgindepend
revert
could
isol
differ
site
link
hspg
depend
ineffici
dissemin
extend
flavivirus
jev
japanes
enceph
viru
wnv
west
nile
viru
mve
murray
valley
enceph
final
recent
studi
mous
model
hepat
b
viru
hbv
infect
also
corrobor
neg
associ
hspg
bind
viral
spread
hbv
undergo
slow
matur
process
hspg
bind
protein
expos
temperatur
timedepend
manner
base
observ
author
suggest
hbv
could
use
process
avoid
becom
trap
blood
stream
hspg
highli
express
infect
would
unproduct
strategi
instead
viru
reach
liver
bind
hspg
infect
cell
via
receptor
sodiumtaurochol
cotransport
polypeptid
ntcp
nonetheless
studi
present
sever
limit
first
anim
model
often
genet
modifi
support
viral
infect
ie
ifn
interferon
receptor
knockout
transgen
express
viral
receptor
second
inocul
virus
animaladapt
final
inocul
rout
infecti
dose
use
far
natur
condit
addit
report
relev
model
thu
necessari
aid
understand
true
impact
hspg
bind
viral
pathogenesi
human
hspg
wide
distribut
cellular
receptor
variou
biolog
activ
receptor
hijack
numer
virus
attach
host
cell
typic
occur
electrostat
interact
neg
charg
hspg
basic
amino
acid
portion
viral
surfac
protein
describ
virus
inher
acquir
abil
bind
hspg
consist
amount
data
support
natur
depend
hsv
denv
hpv
hspg
attach
host
cell
highli
preval
virus
fmdv
rhinovirus
adapt
hspg
occur
extens
passag
cell
absenc
primari
receptor
interestingli
virus
jcv
even
gain
hspgbind
abil
vivo
intrahost
adapt
final
virus
rsv
zikv
hspg
bind
remain
controversi
literatur
contain
contradictori
report
despit
extens
studi
interact
true
impact
receptor
vivo
viral
pathogenesi
remain
also
poorli
understood
case
hspg
bind
appear
promot
dissemin
neurovirul
report
trap
viru
lead
attenu
infect
addit
investig
clinic
viral
strain
condit
close
possibl
nativ
human
infect
clarifi
issu
due
use
mani
distinct
virus
hspg
repres
ideal
broadspectrum
antivir
target
howev
sever
hspgmimick
compound
carrageenan
cellulos
sulfat
pro
fail
phase
iii
clinic
trial
inhibitori
effect
lost
upon
dilut
bodi
fluid
probabl
lead
releas
infecti
particl
recent
success
design
broadspectrum
nontox
antivir
nanoparticl
mimick
hspg
present
irrevers
virucid
inhibit
mechan
addit
effort
direct
aid
develop
antivir
drug
effect
larg
number
exist
virus
also
unpredict
emerg
virus
